Enter your search terms:


Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy

December, 03 2018 at 11:00 AM EST -- Studies show DBF, tentatively named Libervant™, was successfully administered and had similar bioavailability whether given during/immediately following a seizure or between seizures -- DBF, utilizing Aquestive's PharmFilm® technology, is in development as the first oral alternative to injected or...

Aquestive Therapeutics Launches SYMPAZAN™ (clobazam) Oral Film with Widespread U.S. Availability

November, 29 2018 at 12:16 PM EST Establishes extensive Authorized Distributor Network to ensure easy access through retail pharmacies nationwide and mail order WARREN, N.J., Nov. 29, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products...